Story perspectives

Israel Launches Groundbreaking MDMA Therapy for Trauma Recovery

12/29/2025

29 5

Summary

Story summary

About 3 million adults in Israel experience anxiety, depression, or PTSD after Oct. 7, 2023 Hamas-led massacre.
MAPS Israel leads a trial testing 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in a group setting.
The study would be the first global effort to combine MDMA with group therapy.
The study aims to begin by the end of the year.
If successful, the approach could model addressing collective trauma in other countries, such as Ukraine.

1 of 1

Story summary

About 3 million adults in Israel experience anxiety, depression, or PTSD after Oct. 7, 2023 Hamas-led massacre.
MAPS Israel leads a trial testing 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in a group setting.
The study would be the first global effort to combine MDMA with group therapy.
The study aims to begin by the end of the year.
If successful, the approach could model addressing collective trauma in other countries, such as Ukraine.